What is the official website of Novo Nordisk ?

The official website of Novo Nordisk is https://www.novonordisk.com.

What is Novo Nordisk's cybersecurity risk score?

Novo Nordisk has an AI-generated cybersecurity risk score of 802 out of 1000, indicating a Good security posture according to Rankiteo's assessment.

How many security incidents has Novo Nordisk experienced?

According to Rankiteo, Novo Nordisk currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Novo Nordisk been affected by any supply chain cyber incidents ?

According to Rankiteo, Novo Nordisk has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Novo Nordisk have SOC 2 Type 1 certification ?

According to Rankiteo, Novo Nordisk is not certified under SOC 2 Type 1.

Does Novo Nordisk have SOC 2 Type 2 certification ?

According to Rankiteo, Novo Nordisk does not hold a SOC 2 Type 2 certification.

Does Novo Nordisk comply with GDPR ?

According to Rankiteo, Novo Nordisk is not listed as GDPR compliant.

Does Novo Nordisk have PCI DSS certification ?

According to Rankiteo, Novo Nordisk does not currently maintain PCI DSS compliance.

Does Novo Nordisk comply with HIPAA ?

According to Rankiteo, Novo Nordisk is not compliant with HIPAA regulations.

Does Novo Nordisk have ISO 27001 certification ?

According to Rankiteo,Novo Nordisk is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Novo Nordisk operate in ?

Novo Nordisk operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Novo Nordisk have ?

Novo Nordisk employs approximately 65,152 people worldwide.

Does Novo Nordisk own any subsidiaries ?

Novo Nordisk presently has no subsidiaries across any sectors.

How many LinkedIn followers does Novo Nordisk have ?

Novo Nordisk's official LinkedIn profile has approximately 2,662,971 followers.

What is the NAICS classification code for Novo Nordisk ?

Novo Nordisk is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Novo Nordisk have a Crunchbase profile ?

No, Novo Nordisk does not have a profile on Crunchbase.

Does Novo Nordisk have a LinkedIn profile ?

Yes, Novo Nordisk maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/novo-nordisk.

How many cybersecurity incidents has Novo Nordisk experienced ?

As of June 12, 2026, Rankiteo reports that Novo Nordisk has experienced 1 cybersecurity incidents.

How many peer or competitor companies does Novo Nordisk have ?

Novo Nordisk has an estimated 5,685 peer or competitor companies worldwide.

What types of cybersecurity incidents has Novo Nordisk faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Breach.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Novo Nordisk

Boost Score +25 with badge (5 left)

802

/1000

Good

827

/1000

Good

Novo Nordisk Vendor Cyber Rating & Cyber Score

novonordisk.com

Add Your Compliance Badge

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 77,000 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that

Novo Nordisk A.I CyberSecurity Scoring

Scoring History

Novo Nordisk

Novo Nordisk CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

Novo Nordisk

Breach

6/2026

NOV1781195765

Loading…

A.I.

Novo Nordisk Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Novo Nordisk

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Novo Nordisk has 40.12% fewer incidents than the average of same-industry companies with at least one recorded incident.

Incidents vs All-Companies Average (This Year)

Novo Nordisk has 7.41% fewer incidents than the average of all companies with at least one recorded incident.

Incident Types Novo Nordisk vs Pharmaceutical Manufacturing Industry Avg (This Year)

Novo Nordisk reported 1 incidents this year: 0 cyber attacks, 0 ransomware, 0 vulnerabilities, 1 data breaches, compared to industry peers with at least 1 incident.

Incident History - Novo Nordisk (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Novo Nordisk Subsidiaries

Novo Nordisk

Pharmaceutical Manufacturing

Website: https://www.novonordisk.com

Company Size: 10,000+ employees

Novo Nordisk Medical USPharmaceutical Manufacturing

Loading…

Novo Nordisk Similar Companies

MSD

msd.com

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.com and connect with us on Facebook, Instagram, Twitter, and YouTube.

Sanofi

sanofi.com

We are an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines and vaccines that treat and protect millions of people around the world, with an innovative pipeline that could benefit millions more. Our team is guided by one purpose: we chase the miracles of science to improve people’s lives; this inspires us to drive progress and deliver positive impact for our people and the communities we serve, by addressing the most urgent healthcare, environmental, and societal challenges of our time. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms

Zoetis

zoetis.com

The world’s leading animal health company. We’ve been innovating ways to predict, prevent, detect, and treat animal illness for over 70 years, and we continue to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers. Our leading portfolio and pipeline makes a difference in over 100 countries. Community Guidelines: This page is intended to share how Zoetis is advancing care for animals. We aspire to create a supportive community, but there are guidelines to which posts and comments on this page must adhere. If your post references a side effect related to any Zoetis product, we may contact you for more information. To monitor the safety of Zoetis products, we advise you to call our Veterinary Medical Information and Product Support Team at 1-888-963-8471; Support Team is available Mon-Fri 9am to 6:30pm ET. We reserve the right to remove any post/comment that violates LinkedIn Guidelines. As a last resort, we reserve the right to block users that demonstrate a repeated pattern of violating LinkedIn’s spirit of constructive, professional discourse. We respectfully request that you refrain from posting comments including: Unsolicited and/or unverified medical advice Vulgarity and/or profanity Discriminatory and/or derogatory comments, hate speech Politics and religion Personal attacks and/or threats Promotion of illegal activity Copyright/trademark infringements Topics that may be considered spam/advertising Our regular business hours are Mon-Fri 9am to 5pm ET. Zoetis does not endorse and is not responsible for information and opinions shared by community members. The information shared is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. Testimonials represent individual experience only and the experiences and opinions of community members may be unique to the speaker. Terms of Use: https://www.zoetis.com/terms-of-use

Takeda

cb takeda.com

We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our community guidelines: https://takeda.info/communityguidelines

AUROBINDO PHARMA LTD

aurobindo.com

Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, branded specialty drugs, and active pharmaceutical ingredients (APIs) across more than 150 countries. It is ranked among the top 10 generic companies in eight European nations and holds the distinction of being the largest generic pharmaceutical company in the United States. With over 30 state-of-the-art manufacturing and packaging facilities approved by leading global regulatory authorities including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, and Brazil ANVISA, Aurobindo Pharma ensures the highest standards of quality. Its robust portfolio spans eight major therapeutic areas: Central Nervous System (CNS), Antiretroviral (ARV), Cardiovascular (CVS), Antibiotics, Gastroenterology, Anti-diabetics, Oncology, and Dermatology, supported by a strong R&D infrastructure that drives innovation, affordability, and accessibility.

Eli Lilly and Company

lilly.com

We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges. General Information and Guidelines: When you engage with us on LinkedIn, you're agreeing to these Community Guidelines: https://e.lilly/guidelines. If you have questions about a Lilly medicine, contact The Lilly Answers Center at 1-800-Lilly-Rx (1-800-545-5979) Monday through Friday, excluding company holidays.

MENARINI Group

menarini.com

The Menarini Group is a leading international pharmaceutical and diagnostics company, present in 140 countries worldwide, with a turnover of 4,37 Billion euro and more than 17,000 employees. With 9 centers for Research & Development, Menarini’s products are present in the most important therapeutic areas, including cardiology, oncology, gastroenterology, pneumology, infectious diseases, diabetes, and anti-inflammatory/analgesics. The Group’s pharmaceutical production is carried out in its 18 manufacturing plants, which produce over 609 million packets of product a year and distribute them to five continents. Menarini’s pharmaceutical production, in line with the highest quality standards, provides an ongoing contribution to the health of patients all over the world. For further information, please visit www.menarini.com For reading our Netiquette, please visit https://www.menarini.com/en-us/data-privacy/netiquette-of-menarini-group For reading our Privacy Notice for social networks users, please visit https://www.menarini.com/en-us/data-privacy/privacy-notice-for-social-network-users-of-menarini-group

Merck Group

merckgroup.com

This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, and Electronics. Together, we dream big and are passionate about caring for our rich mix of people, customers, patients, and the planet. We believe in the positive power of science and technology. It has determined our actions since 1668 and inspires us to continue researching for a future worth living. As a family-owned company with over 350 years of experience, we stand for sustainability, responsibility, and innovative strength. We take pride in being a diverse and inclusive company that values and fosters the talents and abilities of our employees. That's why we are always looking for curious minds that see themselves imagining the unimaginable with us. Work your Magic and join Merck. Legal Disclaimer: www.merckgroup.com/en/legal-disclaimer.html Data Privacy Declaration: www.merckgroup.com/en/privacy-statement

Astellas Pharma

astellas.com

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines

Loading…

NEWS

Novo Nordisk CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

April 16, 2026 07:00 AM

OpenAI unveils cybersecurity model with limited rollout days after Anthropic’s model

Chat GPT 5.4 Cyber has fewer restrictions for cybersecurity questions for the verified professionals that will use it.View on euronews.

Read Article

April 15, 2026 07:00 AM

AI Weekly: Chipmakers earnings charge, Anthropic's cybersecurity fears

From billions in earnings for chipmakers to Anthropic's cybersecurity concerns, Sean Hogan rounds up the latest stories from the AI...

Read Article

April 14, 2026 07:00 AM

Big Pharma Deepens AI Ties. What It Means For Novo, Novartis.

Novo Nordisk and Novartis deepened their AI ties on Tuesday. Novo signed a deal with OpenAI and Anthropic added Novartis' CEO to its board.

Read Article

April 13, 2026 07:00 AM

Hacker alleges InfoDesk breach affecting pharma, financial firms | brief | SC Media

Cybernews reports that a threat actor claiming to have breached the enterprise intelligence software provider Infodesk has put up the...

Read Article

April 09, 2026 07:00 AM

Cobalt Appoints Cybersecurity Pioneer Tony Spinelli to Board of Directors

SAN FRANCISCO, April 09, 2026--Cobalt, the pioneer of penetration testing as a service (PTaaS) and a leading provider of human-led,...

Read Article

April 07, 2026 07:00 AM

Anthropic claims its new AI model, Mythos, is a cybersecurity ‘reckoning’

Anthropic, the artificial intelligence company that recently fought the Pentagon over the use of its technology, has built a new AI model...

Read Article

April 06, 2026 07:00 AM

Hims & Hers says limited data stolen in social engineering attack

The telehealth provider said hackers gained access to a third-party customer service platform, but medical records remained secure.

Read Article

April 04, 2026 07:00 AM

Mounting Challenges for Hims & Hers: Legal Probes and Data Breach Cloud Outlook

Hims & Hers stock under pressure from securities fraud investigation and cybersecurity incident, despite strong 2025 financial results.

Read Article

March 23, 2026 07:00 AM

RSAC CEO Jen Easterly talks key cybersecurity themes ahead of conference

RSAC CEO Jen Easterly talks key cybersecurity themes ahead of conference.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-53465

SUMMARY

ImageMagick is free and open-source software used for editing and manipulating digital images. Prior to version 7.1.2-25, a crafted multi-frame can result in a heap buffer over-write when encoding it with the SF3 encoder. This issue has been patched in version 7.1.2-25.

Published

Date2026-06-10

Updated

Date2026-06-10

RISK INFORMATION (Score: 6.2)

cvss3

Base Score: 6.2

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H

Impact Score

3.6

Exploitability

2.5

REFERENCES

https://github.com/ImageMagick/ImageMagick/security/advisories/GHSA-44cp-c3ww-9rv5

CVE-2026-53464

SUMMARY

ImageMagick is free and open-source software used for editing and manipulating digital images. Prior to version 7.1.2-25, when providing invalid options to the wand option parser a small memory leak will occur. This issue has been patched in version 7.1.2-25.

Published

Date2026-06-10

Updated

Date2026-06-10

RISK INFORMATION (Score: 4)

cvss3

Base Score: 4.0

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:L

Impact Score

1.4

Exploitability

2.5

REFERENCES

https://github.com/ImageMagick/ImageMagick/security/advisories/GHSA-j989-f892-2335

CVE-2026-53463

SUMMARY

ImageMagick is free and open-source software used for editing and manipulating digital images. Prior to versions 6.9.13-50 and 7.1.2-25, when passing incorrect arguments in the distort operation a null pointer deference will occur. This issue has been patched in versions 6.9.13-50 and 7.1.2-25.

Published

Date2026-06-10

Updated

Date2026-06-10

RISK INFORMATION (Score: 4.3)

cvss3

Base Score: 4.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:N/A:L

Impact Score

1.4

Exploitability

2.8

REFERENCES

https://github.com/ImageMagick/ImageMagick/security/advisories/GHSA-p9rq-q46c-g4x6

CVE-2026-53462

SUMMARY

ImageMagick is free and open-source software used for editing and manipulating digital images. Prior to versions 6.9.13-50 and 7.1.2-25, when an allocation fails in CheckPrimitiveExtent this can result in a heap-use-after-free and result in a crash. This issue has been patched in versions 6.9.13-50 and 7.1.2-25.

Published

Date2026-06-10

Updated

Date2026-06-10

RISK INFORMATION (Score: 5.9)

cvss3

Base Score: 5.9

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:N/I:N/A:H

Impact Score

3.6

Exploitability

2.2

REFERENCES

https://github.com/ImageMagick/ImageMagick/security/advisories/GHSA-px7q-ggqj-hcf2

CVE-2026-53461

SUMMARY

ImageMagick is free and open-source software used for editing and manipulating digital images. Prior to versions 6.9.13-50 and 7.1.2-25, an incorrect loop in the ICON decoder can result in an out of bounds heap write resulting in a crash. This issue has been patched in versions 6.9.13-50 and 7.1.2-25.

Published

Date2026-06-10

Updated

Date2026-06-10

RISK INFORMATION (Score: 7.5)

cvss3

Base Score: 7.5

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H

Impact Score

3.6

Exploitability

3.9

REFERENCES

https://github.com/ImageMagick/ImageMagick/security/advisories/GHSA-g22q-f7gc-5jhr

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…